RecruitingPhase 2NCT02797366

Proton Radiotherapy for Primary Central Nervous System Tumours in Adults

Proton Radiotherapy for Primary Central Nervous System Tumours in Adults - a Prospective Swedish Multicentre Study


Sponsor

Uppsala University

Enrollment

500 participants

Start Date

Aug 1, 2015

Study Type

INTERVENTIONAL

Conditions

Summary

Open label, multi-centre prospective study. Adult patients with primary central nervous system tumours fulfilling the inclusion criteria according to the study protocol. The study consists of 2 sequential cohorts evaluated consecutively for the feasibility, safety and toxicity, as well as long-term survival data, when using spot scanning proton beam therapy.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Proton radiotherapy for people with arteriovenous malformation and central nervous system tumour. The study is currently recruiting participants at 6 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONProton radiotherapy

Locations(6)

Sahlgrenska University Hospital

Gothenburg, Sweden

Linkoeping University Hospital

Linköping, Sweden

Orebro University Hospital

Örebro, Sweden

Karolinska University Hospital

Stockholm, Sweden

Umea University Hospital

Umeå, Sweden

Uppsala University Hospital

Uppsala, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02797366


Related Trials